ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

ClinicalTrials.gov ID: NCT05701774

Public ClinicalTrials.gov record NCT05701774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 10:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study of DCCR (Diazoxide Choline) Extended-Release Tablets in Patients With Prader-Willi Syndrome

Study identification

NCT ID
NCT05701774
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Soleno Therapeutics, Inc.
Industry
Enrollment
83 participants

Conditions and interventions

Interventions

  • DCCR Drug

Drug

Eligibility (public fields only)

Age range
4 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 30, 2023
Primary completion
May 31, 2028
Completion
May 31, 2028
Last update posted
Apr 1, 2025

2023 – 2028

United States locations

U.S. sites
17
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
UC Irvine Orange California 92868
Stanford University Palo Alto California 94304
Rady Children's Hospital of San Diego San Diego California 92123
U of Florida Gainesville Gainesville Florida 32608
Emory Children's Center Atlanta Georgia 30329
Indiana University School of Medicine Indianapolis Indiana 46202
National Institutes of Health Bethesda Maryland 20892
Boston Children's Hospital Boston Massachusetts 02115
Sparrow Clinical Research Institute Lansing Michigan 48912
Children's Hospital and Clinic Minnesota Saint Paul Minnesota 55102
St. Joseph's University Medical Center Paterson New Jersey 07503
NYU Winthrop Hospital Mineola New York 11501
The Research Institute at Nationwide Children's Hospital Columbus Ohio 43205
Vanderbilt University Nashville Tennessee 37212
Research Institute of Dallas Dallas Texas 75231
University of Utah Salt Lake City Utah 84112
Seattle Children's Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05701774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2025 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05701774 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →